Fri, December 20, 2024
Thu, December 19, 2024
[ Thu, Dec 19th 2024 ]: Forbes
13 Must-Read Investing Books
Wed, December 18, 2024

2 FTSE 100 stocks that could outperform the index in 2025

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. cks-that-could-outperform-the-index-in-2025.html
  Print publication without navigation Published in Stocks and Investing on by The Motley Fool UK
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Jon Smith flags up a couple of FTSE 100 stocks that have strong momentum right now and have beaten the index performance this year.
The article from Fool.co.uk, published on December 19, 2024, discusses two FTSE 100 stocks, AstraZeneca and Unilever, which the author believes could outperform the FTSE 100 index in 2025. AstraZeneca is highlighted for its robust pipeline of new drugs, particularly in oncology, and its strategic acquisitions that bolster its growth prospects. Despite a high price-to-earnings ratio, the company's potential for significant earnings growth and its focus on high-value therapies are seen as positive indicators. Unilever, on the other hand, is noted for its defensive qualities, offering stability through its diverse portfolio of essential consumer goods. The company's efforts in innovation, cost management, and its attractive dividend yield make it a compelling choice for investors looking for steady returns. The author suggests that while the FTSE 100 might face volatility, these companies could provide both growth and income, potentially leading to outperformance.

Read the Full The Motley Fool UK Article at:
[ https://www.fool.co.uk/2024/12/19/2-ftse-100-stocks-that-could-outperform-the-index-in-2025/ ]